The European Commission has disclosed a list of potential countermeasures against tariffs imposed by the US should trade negotiations between the two parties fail to reach a mutually beneficial outcome. The measures were submitted to companies and other stakeholders for review on 8 May.
Scientific research across all sectors in the EU will receive more financial support under a plan announced on 5 May by Ursula von der Leyen, president of the European Commission. Speaking at an event at the Sorbonne University in Paris, President von der Leyen outlined four new policies to support research. The first is €500 million in new research funding covering the period from 2025 to 2027. Under this programme, it will be possible for researchers to apply for a new ‘super grant’ giving them seven years of financial support.
GSK Plc expects that turnover will increase by 3 to 5% at constant exchange rates this year, in line with the group’s performance in the first quarter. A more robust increase of 6 to 8% is expected for core operating profit following measures by the company to improve efficiency. The core operating figure excludes the amortisation and impairement of intangible assets.
Targeted protein degradation
Scientists are looking inside the cell
for new drug targets
By Jean-Claude Muller
Research Strategy
The quest for a new RNA
vaccine for Nipah virus
Interview with CEPI
Public Policy
EU outlines strategy on AI
AI pathology tool qualified
Company News - Financing
Isomorphic Labs raises $600 million
Augustine Therapeutics gets Series A
Company News
GSK gets rights to brain shuttle
Regulation and Policy
Haemophilia drug approved
FDA to phase out animal testing
Stock Market Performance
Dismal Q1 for European biotechs
By Robin Davison
Editorial - Stand up for the FDA
(160.87 KB)
